Drug
Dofetilide clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How studies write it
Studies that test it under each name
Name
Brand
Combined with it in one product
Studies by the year they started
4 studies that test it; most in 2006 (1)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 4
Food and Drug Administration (FDA) (3) · University of Pennsylvania (1)
Often tested with
Tested in the same studies.
Ranolazine (2) · Verapamil (2) · Diltiazem (2) · Lopinavir-ritonavir drug combination (1) · Chloroquine (1) · Quinidine (1) · Mexiletine (1) · Lidocaine (1)
Studies
Open first, then newest update. How each study uses dofetilide is read from its arms, and is right about nine times in ten.
Testing it · 4
- CiPA Phase 1 ECG Biomarker Validation StudyCompletedPhase 1Food and Drug Administration (FDA)NCT03070470Written as Dofetilide and Diltiazem
- Study of the Electrocardiographic Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy SubjectsCompletedPhase 1Food and Drug Administration (FDA)NCT01873950Written as Dofetilide
- Ability of Late Sodium or Calcium Current Block to Balance the ECG Effects of Potassium Current BlockCompletedPhase 1Food and Drug Administration (FDA)NCT02308748Written as Dofetilide
- A Study of the Effectiveness of Anti-Arrhythmic Medications After Atrial Fibrillation AblationCompletedNot applicableUniversity of PennsylvaniaNCT00408200Written as propafenone; flecainide; sotalol; dofetilide
Given in every arm · 2 — dofetilide is usual care beside what is tested
- Study of LQT-1213 on QTc-induced Prolongation in Healthy Adult Subjects (Part1) and on Congenital Long QT in Patients Diagnosed With Type 2 or 3 Long QT Syndrome (Part 2).TerminatedPhase 1/2Thryv Therapeutics, Inc.NCT05906732Written as Dofetilide 250 μg Cap
- Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy AdultsCompletedPhase 1Gilead SciencesNCT02365532Written as Dofetilide
As the comparator · 1 — what is tested is compared with dofetilide
Codes
What other systems call dofetilide · ClinicalTrials.gg INT003502
- MeSH (NLM) C063533dofetilideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) R4Z9X1N2NDDOFETILIDEConfirmed FDA, NLM, Wikidata
- RxNorm 49247Confirmed FDA, Wikidata
- Wikidata Q3712521dofetilideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47499DofetilideOne source FDA
- DrugBank DB00204One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C063533 | dofetilide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | R4Z9X1N2ND | DOFETILIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 49247 | — | Confirmed FDA, Wikidata |
| Wikidata | Q3712521 | dofetilide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47499 | Dofetilide | One source FDA |
| DrugBank | DB00204 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.